Register
PMX Global Pharma Directory

Pharmaceutical companies and registered products

Browse pharmaceutical companies and products drawn from public regulatory registration records.

7,053
Directory companies
276,736
Regulatory products
27
Countries represented
6,164 products found

Filters

Film-coated tabletROSUCALROSUVASTATINE20 MGPharma 5Film-coated tabletROSUCALROSUVASTATINE20 MGPharma 5Film-coated tabletROSUCALROSUVASTATINE5 MGPharma 5Film-coated tabletROSUCALROSUVASTATINE5 MGPharma 5Film-coated tabletROSUCALROSUVASTATINE5 MGPharma 5Film-coated tabletROSUVAS SUNROSUVASTATINE20 MGSun Pharmaceuticals North AfricaFilm-coated tabletROSUVAS SUNROSUVASTATINE10 MGSun Pharmaceuticals North AfricaFilm-coated tabletROSUVAS SUNROSUVASTATINE10 MGSun Pharmaceuticals North AfricaOral suspensionROTARIXVACCIN : ROTAVIRUS HUMAIN (SOUCHE RIX4414) (VIVANT, ATTENUE)-GlaxoSmithKlinePowder and solvent for oral suspensionROTARIXVACCIN : ROTAVIRUS HUMAIN (SOUCHE RIX4414) (VIVANT, ATTENUE)-GlaxoSmithKlineOral suspensionROTARIXVACCIN : ROTAVIRUS HUMAIN (SOUCHE RIX4414) (VIVANT, ATTENUE)-GlaxoSmithKlineOral suspensionROTARIXVACCIN : ROTAVIRUS HUMAIN (SOUCHE RIX4414) (VIVANT, ATTENUE)-GlaxoSmithKlineLyophilisate for oral solutionROTASIILROTAVIRUS REASSORTI BOVIN-HUMAIN VIVANT ATTENUE (G1, G2, G3, G4, G9)10 5,6 UFF / SEROTYPEInstitut Pasteur du MarocLyophilisate for oral solutionROTASIILROTAVIRUS REASSORTI BOVIN-HUMAIN VIVANT ATTENUE (G1, G2, G3, G4, G9)10 5,6 UFF / SEROTYPEInstitut Pasteur du MarocLyophilisate for oral solutionROTASIILROTAVIRUS REASSORTI BOVIN-HUMAIN VIVANT ATTENUE (G1, G2, G3, G4, G9)10 5,6 UFF / SEROTYPEInstitut Pasteur du MarocLyophilisate for oral solutionROTASIILROTAVIRUS REASSORTI BOVIN HUMAIN VIVANT ATTENUE (G1,G2,G3,G4 ET G9)10 5,6 UFF / SEROTYPEInstitut Pasteur du MarocOral solutionROTASIIL-LIQUIDROTAVIRUS REASSORTI BOVIN-HUMAIN VIVANT ATTENUE (G1, G2, G3, G4, G9)≥10 ^5,6 U FF / SEROTYPEInstitut Pasteur du MarocOral solutionROTATEQVACCIN : ROTAVIRUS REASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT) // ROTAVIRUS REASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT) // ROTAVIRUS REASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT) // G4 REASSORTANT // P1 REASSORTANT3,01 * 106 UI / DOSE / 4,39 * 106 UI / DOSE / 5,98 * 106 UI / DOSE / 3,51 * 106 UI / DOSE / 4,13 * 106 UI / DOSEMerck Sharp & DohmeOral solutionROTATEQVACCIN : ROTAVIRUS REASSORTANT HUMAIN-BOVIN DE TYPE G1 (VIVANT) // ROTAVIRUS REASSORTANT HUMAIN-BOVIN DE TYPE G2 (VIVANT) // ROTAVIRUS REASSORTANT HUMAIN-BOVIN DE TYPE G3 (VIVANT) // G4 REASSORTANT // P1 REASSORTANT3,01 * 106 UI / DOSE / 4,39 * 106 UI / DOSE / 5,98 * 106 UI / DOSE / 3,51 * 106 UI / DOSE / 4,13 * 106 UI / DOSEMerck Sharp & DohmeFilm-coated tabletROVAMYCINESPIRAMYCINE1,5 MUIMapharFilm-coated tabletROVAMYCINESPIRAMYCINE3 MUIMapharFilm-coated tabletROVAMYCINESPIRAMYCINE3 MUIMapharGastro-resistant coated tabletROWASAMESALAZINE500 MGMapharSuppositoryROXAMPIROXICAM20 MGNovopharma

Last updated in PMX directory: Oct 15, 2026